Rubicon Research Limited (BOM:544578)
India · Delayed Price · Currency is INR 1,725.25
-36.95 (-2.10%)
At close: Aug 21, 2026
Rubicon Research Market Cap
Rubicon Research has a market cap or net worth of 285.49 billion as of August 21, 2026.
Market Cap
285.49B
Enterprise Value
285.27B
Revenue
19.36B
Ranking
n/a
PE Ratio
99.06
Stock Price
1,725.25
ChartMarket Cap Chart
Since October 16, 2025, Rubicon Research's market cap has increased from 103.50B to 285.49B, an increase of 175.85%. That is a compound annual growth rate of 231.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 285.49B | 154.55% |
| Dec 31, 2025 | 112.15B | 8.37% |
| Oct 16, 2025 | 103.50B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Abbott India | 557.70B |
| GlaxoSmithKline Pharmaceuticals | 491.21B |
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Rubicon Research | 285.49B |
| Granules India | 212.72B |
| Caplin Point Laboratories | 194.45B |
| AstraZeneca Pharma India | 185.26B |
| Jubilant Pharmova | 139.25B |